Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29976 - 30000 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Decitabine	Approved Investigational	WDR66	144406	upregulated	decitabine results in increased expression of WDR66 mRNA	12q24.31	A21915
Decitabine	Approved Investigational	WIF1	11197	upregulated	decitabine results in increased expression of WIF1 mRNA	12q14.3	A21919 A21918
Decitabine	Approved Investigational	WRB	7485	upregulated	decitabine results in increased expression of WRB mRNA	21q22.2	A21912
Decitabine	Approved Investigational	XAB2	56949	upregulated	decitabine results in increased expression of XAB2 mRNA	19p13.3	A21917
Decitabine	Approved Investigational	XAF1	54739	upregulated	decitabine results in increased expression of XAF1 mRNA	17p13.2	A22048 A22049 A21945
Decitabine	Approved Investigational	XAGE1B	653220	upregulated	decitabine results in increased expression of XAGE1B mRNA	Xp11.22	A21991 A21986
Decitabine	Approved Investigational	XAGE1E	653067	upregulated	decitabine results in increased expression of XAGE1E mRNA	Xp11.22	A21955
Decitabine	Approved Investigational	XPC	7508	downregulated	decitabine results in decreased expression of XPC mRNA	3p25.1	A21181
Decitabine	Approved Investigational	YY2	404281	upregulated	decitabine results in increased expression of YY2 mRNA	Xp22.12	A22050
Decitabine	Approved Investigational	ZC3H3	23144	downregulated	decitabine results in decreased expression of ZC3H3 mRNA	8q24.3	A21913
Decitabine	Approved Investigational	ZNF157	7712	upregulated	decitabine results in increased expression of ZNF157 mRNA	Xp11.3	A21915
Decitabine	Approved Investigational	ZNF177	7730	upregulated	decitabine results in increased expression of ZNF177 mRNA	19p13.2	A21919
Decitabine	Approved Investigational	ZNF229	7772	upregulated	decitabine results in increased expression of ZNF229 mRNA	19q13.2	A21915
Decitabine	Approved Investigational	ZNF559	84527	upregulated	decitabine results in increased expression of ZNF559 mRNA	19p13.2	A21919
Decitabine	Approved Investigational	ZSCAN4	201516	upregulated	decitabine results in increased expression of ZSCAN4 mRNA	19q13.43	A21915
Deferiprone	Approved Investigational	FXN	2395	upregulated	deferiprone results in increased expression of FXN mRNA	9q21.11	A21394
Deferiprone	Approved Investigational	TF	7018	upregulated	deferiprone results in increased expression of TF mRNA	3q22.1	A22051
Deferoxamine	Approved Investigational	ADM	133	upregulated	Deferoxamine results in increased expression of ADM mRNA	11p15.4	A22052
Deferoxamine	Approved Investigational	ALDH3A1	218	downregulated	Deferoxamine results in decreased expression of ALDH3A1 mRNA	17p11.2	A22053
Deferoxamine	Approved Investigational	ASH2L	9070	upregulated	Deferoxamine results in increased expression of ASH2L mRNA	8p11.23	A22054
Deferoxamine	Approved Investigational	BAX	581	upregulated	Deferoxamine results in increased expression of BAX mRNA	19q13.33	A22055
Deferoxamine	Approved Investigational	CA9	768	upregulated	Deferoxamine results in increased expression of CA9 mRNA	9p13.3	A22056
Deferoxamine	Approved Investigational	CDC14A	8556	upregulated	Deferoxamine results in increased expression of CDC14A mRNA alternative form	1p21.2	A22057
Deferoxamine	Approved Investigational	CDKN1A	1026	upregulated	Deferoxamine results in increased expression of CDKN1A mRNA	6p21.2	A22058 A22059
Deferoxamine	Approved Investigational	CXCL8	3576	upregulated	Deferoxamine results in increased expression of CXCL8 mRNA	4q13.3	A22060

Displaying entries 29976 - 30000 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability